Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. BMS-986326 (IL-2/CD25) is under development for the treatment of ...

BMS is headquartered in Princeton, New Jersey, the US. For a complete picture of IL2-CD25’s drug-specific PTSR and LoA scores, buy the report here. GlobalData, the leading provider of industry ...

1 Laboratory of Molecular Cell Biology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan 2 Department of Microbiology and Immunology, Tohoku University ...

Clinical and Radiographic Outcomes of Four Different Treatment Strategies in Patients With Early Rheumatoid Arthritis (the Best Study): A Randomized, Controlled Trialfrom Arthritis & Rheumatism ...

Therefore, ensuring an accurate and reproducible rating of each domain, by providing a more detailed definition of each domain ... 1 and EULAR Sjögren's syndrome patient reported index (ESSPRI).2 The ...